BGM0504
A Study of BGM0504 in Participants With Obesity
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 96
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| BGM0504 | n/r | n/r | n/r | n/r | n/r |
| Tirzepatide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.